Score Overview
XBiotech Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 43M to $ 0.00 and net income went from -$ 11M to -$ 45M. Revenue increased in 0 of those 5 years; net income in 2.
XBiotech Inc currently holds a 5-year HDB Score of 2.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.46 | — |
1 Year2025-08-12 | $ 2.97 | -17.17% |
5 Years2021-08-12 | $ 16.06 | -84.68% |
10 Years2016-08-12 | $ 13.29 | -81.49% |
All Time2015-04-15 | $ 20.03 | -87.72% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-04-15 |
|---|---|---|---|---|---|
| Price | $ 2.46 | $ 2.97 | $ 16.06 | $ 13.29 | $ 20.03 |
| Return | — | -17.17% | -84.68% | -81.49% | -87.72% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 40M | $ 115M |
| 2025 | $ 0.00 | -$ 45M | $ 125M |
| 2024 | $ 0.00 | -$ 38M | $ 172M |
| 2023 | $ 300K | -$ 24M | $ 200M |
| 2022 | $ 4M | -$ 32M | $ 217M |
| 2021 | $ 18M | -$ 17M | $ 236M |
| 2020 | $ 43M | -$ 11M | $ 237M |
| 2019 | $ 12M | $ 668M | $ 714M |
| 2018 | $ 0.00 | -$ 21M | $ 15M |
| 2017 | $ 0.00 | -$ 33M | $ 31M |
| 2016 | $ 0.00 | -$ 52M | $ 34M |
| IPO2015 | $ 0.00 | -$ 37M | $ 91M |
Explore beyond XBIT
You're looking at XBiotech Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.